These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37568073)
1. Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma. Ji J; Liu S; Liang Y; Zheng G BMC Genom Data; 2023 Aug; 24(1):44. PubMed ID: 37568073 [TBL] [Abstract][Full Text] [Related]
2. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma. Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578 [TBL] [Abstract][Full Text] [Related]
3. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer. Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer. Liu J; Wang J; Wu M; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J Front Med (Lausanne); 2021; 8():757432. PubMed ID: 35004726 [No Abstract] [Full Text] [Related]
5. Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Liu Y; Li G; Yang Y; Lu Z; Wang T; Wang X; Liu J Front Genet; 2021; 12():752025. PubMed ID: 35046996 [No Abstract] [Full Text] [Related]
7. Molecular Characteristics of m6A Regulators and Tumor Microenvironment Infiltration in Soft Tissue Sarcoma: A Gene-Based Study. Xiao KW; Yang ZQ; Yan X; Liu ZB; Yang M; Guo LY; Cai L Front Bioeng Biotechnol; 2022; 10():846812. PubMed ID: 35519620 [No Abstract] [Full Text] [Related]
8. Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration. Yue Q; Zhang Y; Wang F; Cao F; Bai J; Duan X J Immunol Res; 2022; 2022():8766735. PubMed ID: 35692505 [TBL] [Abstract][Full Text] [Related]
9. m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment. Zhang W; Xiao P; Tang J; Wang R; Wang X; Wang F; Ruan J; Yu S; Tang J; Huang R; Zhao X Front Immunol; 2022; 13():888650. PubMed ID: 35572541 [TBL] [Abstract][Full Text] [Related]
10. Integrating m6A Regulators-Mediated Methylation Modification Models and Tumor Immune Microenvironment Characterization in Caucasian and Chinese Low-Grade Gliomas. Liu W; Li C; Wu Y; Xu W; Chen S; Zhang H; Huang H; Zhao S; Wang J Front Cell Dev Biol; 2021; 9():725764. PubMed ID: 34900988 [No Abstract] [Full Text] [Related]
11. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Huang X; Qiu Z; Li L; Chen B; Huang P Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607 [TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic m6A modification patterns and score system in melanoma patients. Wang F; Chen P; Ouyang S; Xiong K; Liu Z; Wang Y Medicine (Baltimore); 2024 Apr; 103(17):e37950. PubMed ID: 38669381 [TBL] [Abstract][Full Text] [Related]
13. m6A modification patterns are associated with copy number burden and tumor immune landscape in thyroid cancer. Cai L; Liu T; Hua H; Jiang X; Qian L BMC Endocr Disord; 2023 Dec; 23(1):271. PubMed ID: 38057752 [TBL] [Abstract][Full Text] [Related]
14. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer. Yang Q; Xu F; Jian A; Yu H; Ye T; Hu W Front Cell Dev Biol; 2021; 9():803141. PubMed ID: 35198565 [No Abstract] [Full Text] [Related]
15. N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma. Wang G; Zeng D; Sweren E; Miao Y; Chen R; Chen J; Wang J; Liao W; Hu Z; Kang S; Garza LA J Invest Dermatol; 2023 Aug; 143(8):1579-1590.e5. PubMed ID: 36842525 [TBL] [Abstract][Full Text] [Related]
16. M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy. Zhao K; Wei B; Zhang Y; Shi W; Zhang G; Wang Z Front Pharmacol; 2022; 13():1052177. PubMed ID: 36438800 [No Abstract] [Full Text] [Related]
17. Novel RNA N6-methyladenosine regulator related signature for predicting clinical and immunological characteristics in breast cancer. Zhang J; Liu G; Dai Z; Xie F; Zheng R; Yuan B; Guo L Gene; 2023 Feb; 853():147095. PubMed ID: 36464173 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer. Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer. Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X Front Immunol; 2022; 13():976107. PubMed ID: 36091006 [TBL] [Abstract][Full Text] [Related]
20. m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma. Li J; Wang W; Zhou Y; Liu L; Zhang G; Guan K; Cui X; Liu X; Huang M; Cui G; Sun R Front Cell Dev Biol; 2021; 9():687756. PubMed ID: 34277630 [No Abstract] [Full Text] [Related] [Next] [New Search]